MINNEAPOLIS– Medtronic, Inc. today announced the first patient enrollment in a global, multicenter, randomized clinical trial comparing the Medtronic CoreValve® System with surgical aortic valve ...

MINNEAPOLIS – Medtronic, Inc.today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve ...

Since 2007 Transcatheter Aortic Valve Implantation (TAVI) has become an alternative treatment for elderly patients with severe aortic stenosis at high risk for surgical aortic valve replacement. At ...

Patients implanted with the CoreValve transcatheter aortic valve replacement showed strong blood flow and improved quality of life at five years post-implant, according to results from two Medtronic ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received ...

5451 La Palma: one of two medical-office properties changing hands in La Palma Medtronic Inc. is proceeding with key trials of a less-invasive replacement heart valve it developed here. The ...

In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year ...

WASHINGTON, March 29 (Reuters) - Medtronic Inc's minimally invasive CoreValve system for replacing diseased aortic heart valves led to a significantly higher survival rate after one year than ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In transcatheter aortic valve replacement for severe ...

Nontransfemoral implantation, however, was not an independent predictor of mortality and likely reflected the higher risk of the patients treated this way. What's to Be Gleaned From UK TAVI? Speaking ...

ANN ARBOR, Mich. – The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to ...

This section describes safety outcomes from the published literature that the committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see the ...